136 related articles for article (PubMed ID: 3939152)
21. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
[TBL] [Abstract][Full Text] [Related]
22. [Varicella disease and varicella vaccine. A literature review].
Frederiksen MS; Plesner AM; Stellfeld M
Ugeskr Laeger; 2003 Jun; 165(23):2387-91. PubMed ID: 12840997
[TBL] [Abstract][Full Text] [Related]
23. An economic analysis of the universal varicella vaccination program in the United States.
Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
[TBL] [Abstract][Full Text] [Related]
24. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
25. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
26. Varicella prevention in the United States: a review of successes and challenges.
Marin M; Meissner HC; Seward JF
Pediatrics; 2008 Sep; 122(3):e744-51. PubMed ID: 18762511
[TBL] [Abstract][Full Text] [Related]
27. [Costs and benefits of measles vaccination].
Ambrosch F; Wiedermann G; Harasek G
Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
Bonanni P; Boccalini S; Bechini A; Banz K
Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
[TBL] [Abstract][Full Text] [Related]
29. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
[TBL] [Abstract][Full Text] [Related]
30. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
Shinefield HR; Black S; Kuter BJ
J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
[TBL] [Abstract][Full Text] [Related]
31. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
Goldman GS
Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of varicella vaccination of healthcare workers.
Chodick G; Ashkenazi S; Livni G; Lerman Y
Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
[TBL] [Abstract][Full Text] [Related]
33. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
34. Varicella: the vaccine and the public health debate.
Niederhauser VP
Nurse Pract; 1999 Mar; 24(3):74-6, 79, 83-4 passim. PubMed ID: 10100242
[TBL] [Abstract][Full Text] [Related]
35. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy.
Gialloreti LE; Divizia M; Pica F; Volpi A
Herpes; 2005 Oct; 12(2):33-7. PubMed ID: 16209858
[TBL] [Abstract][Full Text] [Related]
38. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
[TBL] [Abstract][Full Text] [Related]
39. [Varicella vaccine].
Abarca Villaseca K
Rev Chilena Infectol; 2006 Mar; 23(1):56-9. PubMed ID: 16462966
[TBL] [Abstract][Full Text] [Related]
40. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses.
Azzari C; Massai C; Poggiolesi C; Indolfi G; Spagnolo G; De Luca M; Gervaso P; de Martino M; Resti M
Curr Med Res Opin; 2007 Dec; 23(12):2945-54. PubMed ID: 17937842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
